Deciphera Pharmaceuticals, Inc. Share Price: DCPH (Deciphera Pharmaceuticals, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Deciphera Pharmaceuticals, Inc. share price today?

Accepted Answer

Deciphera Pharmaceuticals, Inc. (DCPH) share price today is {{live_price}}.

Question 2

Can Indians buy Deciphera Pharmaceuticals, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Deciphera Pharmaceuticals, Inc. (DCPH) from India.

With INDmoney, you can buy Deciphera Pharmaceuticals, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Deciphera Pharmaceuticals, Inc. at zero transaction cost.

Question 3

How can I buy Deciphera Pharmaceuticals, Inc. shares from India?

Accepted Answer

It is very easy to buy Deciphera Pharmaceuticals, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Deciphera Pharmaceuticals, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Deciphera Pharmaceuticals, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Deciphera Pharmaceuticals, Inc. stocks?

Accepted Answer

To start investing in Deciphera Pharmaceuticals, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Deciphera Pharmaceuticals, Inc.

Accepted Answer

Today’s highest price of Deciphera Pharmaceuticals, Inc. (DCPH) is {{1_rba_end}}.

Today’s lowest price of Deciphera Pharmaceuticals, Inc. (DCPH) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Deciphera Pharmaceuticals, Inc.

Accepted Answer

Today's market capitalisation of Deciphera Pharmaceuticals, Inc. DCPH is 1.2B

Question 8

What is the 52 Week High and Low Range of Deciphera Pharmaceuticals, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Deciphera Pharmaceuticals, Inc. is down from its 52 Week High?

Accepted Answer

Deciphera Pharmaceuticals, Inc. (DCPH) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Deciphera Pharmaceuticals, Inc. is up from its 52 Week low?

Accepted Answer

Deciphera Pharmaceuticals, Inc. (DCPH) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Deciphera Pharmaceuticals, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Deciphera Pharmaceuticals, Inc.

Accepted Answer

Mr. Steven L. Hoerter is the current Chief Executive Officer (CEO) of Deciphera Pharmaceuticals, Inc..

Period	Deciphera Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	5.98%	-0.7%	0.0%
6 Months	36.04%	6.6%	0.0%
1 Year	-3.85%	3.7%	-1.5%
3 Years	-67.43%	14.0%	-21.8%

Market Capitalization	1.2B
Book Value	$4.36
Earnings Per Share (EPS)	-2.29
Wall Street Target Price	24.2

Profit Margin	-119.34%
Operating Margin TTM	-106.1%

Return On Assets TTM	-28.43%
Return On Equity TTM	-56.29%

Revenue TTM	163.4M
Revenue Per Share TTM	1.92
Quarterly Revenue Growth YOY	32.9%
Gross Profit TTM	-62.6M
EBITDA	-208.9M
Diluted Eps TTM	-2.29
Quarterly Earnings Growth YOY	0.0

Deciphera Pharmaceuticals, Inc. (DCPH)

Increasing Revenue

Increasing Net Profit

Vs CTLT

Vs NBIX

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Deciphera Pharmaceuticals, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-2.16
EPS Estimate Next Year	-1.7
EPS Estimate Current Quarter	-0.58
EPS Estimate Next Quarter	-0.59

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Deciphera Pharmaceuticals, Inc.	-0.88%	36.04%	-3.85%	-67.43%	-37.23%
Neurocrine Biosciences Inc.	-4.45%	18.72%	28.45%	40.46%	69.87%
Haleon Plc Spon Ads	-0.12%	-1.82%	-7.31%	9.45%	9.45%
Zoetis Inc.	-10.98%	-10.38%	-12.9%	-9.61%	53.43%
Viatris Inc.	-5.61%	18.46%	12.35%	-16.23%	-32.07%
Catalent, Inc.	0.0%	24.33%	32.98%	-48.49%	27.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Deciphera Pharmaceuticals, Inc.	NA	NA	NA	-2.16	-0.56	-0.28	NA	4.36
Neurocrine Biosciences Inc.	53.84	53.84	0.44	4.78	0.13	0.09	NA	22.61
Haleon Plc Spon Ads	28.93	28.93	1.69	0.45	0.07	0.04	0.03	1.8
Zoetis Inc.	29.48	29.48	2.58	5.8	0.5	0.13	0.01	10.9
Viatris Inc.	222.4	222.4	NA	2.78	0.0	0.03	0.04	17.05
Catalent, Inc.	211.02	NA	2.06	0.48	-0.3	-0.01	NA	20.41

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Deciphera Pharmaceuticals, Inc.	Buy	$1.2B	-37.23%	NA	-119.34%
Neurocrine Biosciences Inc.	Buy	$13.4B	69.87%	53.84	13.23%
Haleon Plc Spon Ads	Buy	$37.0B	9.45%	28.93	9.28%
Zoetis Inc.	Buy	$68.5B	53.43%	29.48	27.43%
Viatris Inc.	Hold	$13.2B	-32.07%	222.4	0.35%
Catalent, Inc.	Hold	$10.1B	27.27%	211.02	-31.77%

Organization	Deciphera Pharmaceuticals, Inc.
Employees	355
CEO	Mr. Steven L. Hoerter
Industry	Health Technology